Partner Headlines - ESRX

  1. Earnings Recap For February 16

    Benzinga
  2. Chris Davis Buys More Than 13 Million Shares of Apache Corporation

    GuruFocus
  3. Keep an Eye on These 7 Stocks for February 16, 2016

    Benzinga
  4. Benzinga's Top Downgrades

    Benzinga
  5. Steven Romick Sells Microsoft, Walgreens, CVS

    GuruFocus
  6. Mike Khouw Sees Unusual Options Activity In Express Scripts

    Benzinga
  7. Anthem Looms Over Express

    IBD
  8. Express Scripts Gets Mixed Reviews After '16 Guidance

    IBD
  9. Stock Futures Trim Early Gains; Express Scripts, Spirit Air Climb

    IBD
  10. Benzinga's Top #PreMarket Gainers

    Benzinga
  11. First Pacific Advisors Slashes Stake in CVS Health

    GuruFocus
  12. Valeant To Cut Drug Prices In Team-Up With Walgreens

    IBD
  13. Health Care Stocks Play Prominent Roles in Steven Romick's Transactions

    GuruFocus
  14. Glenn Greenberg Sells Stake in Express Scripts Holding

    GuruFocus
  15. Motif Alert: Buybacks Have Bounced All The Way Back

    Benzinga
  16. Early Global News: Morgan Stanley To Cut Bond And Currency Trading ...

    Benzinga
  17. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  18. Express Scripts to Partner With Imprimis Pharmaceuticals to Offer ...

    Benzinga
  19. Premera Blue Cross and Express Scripts Agree to Contract Extension

    Benzinga
  20. Are Buybacks At Apple, Nike, Other Firms Good Or Bad?

    IBD
  21. CVS' Amgen Pick 'Raises The Bar' For Regeneron, Sanofi

    IBD
  22. Horizon Pharma Stock Rises After Depomed Chase Ends

    IBD
  23. Dodge & Cox Comments on Express Scripts

    GuruFocus
  24. Jeremy Grantham Adds to Stakes in Pharmaceutical Stocks

    GuruFocus
  25. Gilead, Regeneron Stocks Weather Drug Pricing Furor

    IBD
  26. Express Sues Horizon Pharma

    IBD
  27. Stocks End Modestly Lower; Popeyes Cooking After Hours

    IBD
  28. Horizon Slams Express Scripts Amid Pharmacy Dispute

    IBD
  29. Stock Futures Climb Toward Open; Facebook, LinkedIn, Alphabet ...

    IBD
  30. Horizon Pharma Soars On Big Q3 Beat, Guidance Raise

    IBD
  31. Valeant Dumps Philidor, Falls

    IBD
  32. Valeant Dumps Philidor As Stock Keeps Hemorrhaging

    IBD
  33. How Rite Aid Deal Will Change Walgreens

    GuruFocus
  34. Valeant Dumps Philidor As Stock Keeps Hemorrhaging

    IBD
  35. Herbalife Jabs Bill Ackman Over Troubled Valeant

    FoxBusiness
  36. Valeant Falls On CVS, Express

    IBD
  37. Valeant Hit As CVS, Express Scripts Dump Philidor

    IBD
  38. EXPRESS SCRIPTS

    IBD
  39. Walgreens Will Buy Rival Rite Aid In $17.2 Bil Deal

    IBD
  40. Steven Romick Sells CVS, Buys United Technologies

    GuruFocus
  41. Tuesday's After-Hours Movers: Apple And Twitter Lead The Way

    Benzinga
  42. Rite Aid Spikes 39% On Reported Walgreens Buy Talks

    IBD
  43. Horizon Pharma Counters Depomed Hit On Drug Pricing

    IBD
  44. FDA Ruling Shakes Up Biotech: Gilead, AbbVie And More

    Benzinga
  45. Stocks Near Flatline; Bad News for Lilly Is Good News For Regeneron

    IBD
  46. Stocks Fade After Solid Start; Tesla, Adobe Weigh On Nasdaq

    IBD
  47. Regeneron, Amgen Up As PCSK9s Gain Key Coverage

    IBD
  48. Stocks Surge In Mixed Volume; Amgen, Global Payments Rocket

    IBD
  49. EXPRESS SCRIPTS

    IBD
  50. Apple, Microsoft Lead '15 Payout Hikes But Pace Slows

    IBD
  51. Companies Returning Money to Shareholders at Record Rate

    GuruFocus
  52. Slowing Buybacks Drag On Buyback ETFs

    Benzinga
  53. Glenn Greenberg Acquires Two New Stakes

    GuruFocus
  54. Jeremy Grantham Reduces More Than 250 Stakes in Second Quarter

    GuruFocus
  55. Vanguard Health Care Fund Buys Two New Stakes in Second Quarter

    GuruFocus
  56. EXPRESS SCRIPTS

    IBD
  57. UnitedHealth Beats Views, Sits Pretty As Rivals Merge

    IBD
  58. UnitedHealth Set For Q2 Earnings Amid Deal Chatter

    IBD
  59. Will Bill Ackman Go After Express Scripts Next?

    GuruFocus
  60. Acquisitions May Fuel Gilead Sciences' Winning Ways

    IBD
  61. Horizon Pharma Seen In Deal-Making Mode

    IBD
  62. McKesson Sees Healthy Growth In Prescription Drugs

    IBD
  63. David Rolfe Adds to Most Valuable Stakes in His Portfolio

    GuruFocus
  64. Regeneron/Sanofi Cholesterol Drug Wins FDA Panel Vote

    IBD
  65. Gilead Nears Buy Zone On Healthy Drug Trial Results

    IBD
  66. Why Diplomat Pharmacy Gains Since IPO Look So Healthy

    IBD
  67. Horizon Pharma Survives Through Transformation

    IBD
  68. Morning Market Losers

    Benzinga
  69. Benzinga's Top Downgrades

    Benzinga
  70. Raymond James Downgrades Express Scripts Holding To Market Perform

    Benzinga
  71. Dodge & Cox Keeps Buying Express Scripts

    GuruFocus
  72. Pay-For-Performance Medicine

    Benzinga
  73. Making Money With Charles Payne: 05/26/15

    FoxBusiness
  74. Horizon Pharma Up On Bullish Leerink Initiation

    IBD
  75. CVS Health Buys Omnicare, Citing 'Long-Term' Benefits

    IBD
  76. Drug 'super spending' soars

    IBD
  77. 20 Questions With David Rolfe Part I

    GuruFocus
  78. Addiction Care Provider AAC Eyes National Brand

    IBD
  79. Medivation, Jazz Q1 Reports Miss; Regeneron Beats

    IBD
  80. Regeneron Q1 Earnings Beat As Eylea Research Pays Off

    IBD
  81. GoPro, Other Earnings Trigger Wild Price Swings

    IBD
  82. EXPRESS SCRIPTS

    IBD
  83. Express Scripts Posts In-Line Q1 Earnings, Issues Strong Forecast

    Benzinga
  84. Stocks Stumble To Early Losses; IPG Photonics Jumps

    IBD
  85. Why CVS Health And McKesson May Be Good Stock Picks

    IBD
  86. UnitedHealth Profit Soars On ObamaCare, Optum

    IBD
  87. UnitedHealth Up After Topping Views, Raising Outlook

    IBD
  88. UnitedHealth Eyes Biggest Earnings Gain In Years

    IBD
  89. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD
  90. Horizon Pharma Soars On Q4 Beat, Guidance Raise

    IBD
  91. Catamaran EPS Tops, But Stock Falls On Weak Guidance

    IBD
  92. 10 Stocks You Should Be Watching Today

    Benzinga
  93. EXPRESS SCRIPTS

    IBD
  94. UPDATE: Express Scripts Tops Q4 Expectations, Shares Rise After ...

    Benzinga
  95. Nasdaq Stretches Win Streak To 9 Days

    IBD
  96. Earnings Scheduled For February 23, 2015

    Benzinga
  97. Must Watch Stocks for Today

    Benzinga
  98. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD
  99. Rolfe Adds One Company to Portfolio in Fourth Quarter

    GuruFocus
  100. Analyzing Needham Growth Fund's Pick: Express Scripts (ESRX)

    GuruFocus
Trading Center